Last 12 months
Inside the activity.
0 purchase rows · 64 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 24 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2024 Filed Feb 28, 2024 22:04 UTC |
GREEN ANDREW MVP Regulatory
|
SaleCommon Stock | 1,218 | $20.27 | $24,690.20 |
DisclosureSEC source: 0000784199-24-000061 · wk-form4_1709157861.xml · nonDerivative · entry 4 GREEN ANDREW M · CIK 0001191000 · VP Regulatory 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,544 F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 22:04 UTC |
GREEN ANDREW MVP Regulatory
|
SaleCommon Stock | 1,185 | $20.27 | $24,021.25 |
DisclosureSEC source: 0000784199-24-000061 · wk-form4_1709157861.xml · nonDerivative · entry 2 GREEN ANDREW M · CIK 0001191000 · VP Regulatory 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,848 F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 22:01 UTC |
Stanton Marshall S.SVP, Clinical & MD Affair
|
SaleCommon Stock | 1,448 | $20.27 | $29,352.55 |
DisclosureSEC source: 0000784199-24-000059 · wk-form4_1709157669.xml · nonDerivative · entry 4 Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,685 F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 22:01 UTC |
Stanton Marshall S.SVP, Clinical & MD Affair
|
SaleCommon Stock | 1,600 | $20.27 | $32,433.76 |
DisclosureSEC source: 0000784199-24-000059 · wk-form4_1709157669.xml · nonDerivative · entry 2 Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,489 F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 21:58 UTC |
Tyrs FlorianVP, Global Operations
|
SaleCommon Stock | 893 | $20.27 | $18,103.07 |
DisclosureSEC source: 0000784199-24-000057 · wk-form4_1709157504.xml · nonDerivative · entry 1 Tyrs Florian · CIK 0001983377 · VP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,897 F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| February 26, 2024 Filed Mar 15, 2024 00:38 UTC Amendment |
Horton AmyVP, Chief Accounting Officer
|
SaleCommon Stock | 966 | $20.27 | $19,581.88 |
DisclosureSEC source: 0000784199-24-000156 · wk-form4a_1710463100.xml · nonDerivative · entry 4 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,888 F5 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 980 shares were sold, when in fact, 966 shares were sold. F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| February 26, 2024 Filed Mar 15, 2024 00:38 UTC Amendment |
Horton AmyVP, Chief Accounting Officer
|
SaleCommon Stock | 1,168 | $20.27 | $23,676.64 |
DisclosureSEC source: 0000784199-24-000156 · wk-form4a_1710463100.xml · nonDerivative · entry 2 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,436 F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 1,186 shares were sold, when in fact, 1,168 shares were sold. F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| February 26, 2024 Filed Mar 15, 2024 00:36 UTC Amendment |
Stanton Marshall S.SVP, Clinical & MD Affair
|
SaleCommon Stock | 1,431 | $20.27 | $29,007.94 |
DisclosureSEC source: 0000784199-24-000154 · wk-form4a_1710462983.xml · nonDerivative · entry 4 Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,726 F5 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 1,448 shares were sold, when in fact, 1,431 shares were sold. F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| February 26, 2024 Filed Mar 15, 2024 00:36 UTC Amendment |
Stanton Marshall S.SVP, Clinical & MD Affair
|
SaleCommon Stock | 1,576 | $20.27 | $31,947.25 |
DisclosureSEC source: 0000784199-24-000154 · wk-form4a_1710462983.xml · nonDerivative · entry 2 Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,513 F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 1,600 shares were sold, when in fact, 1,576 shares were sold. F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| February 26, 2024 Filed Mar 15, 2024 00:33 UTC Amendment |
Maney Rochelle L.VP, Quality
|
SaleCommon Stock | 1,114 | $20.27 | $22,582.01 |
DisclosureSEC source: 0000784199-24-000152 · wk-form4a_1710462815.xml · nonDerivative · entry 4 Maney Rochelle L. · CIK 0001850597 · VP, Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,518 F5 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 1,130 shares were sold, when in fact, 1,114 shares were sold. F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| February 26, 2024 Filed Mar 15, 2024 00:33 UTC Amendment |
Maney Rochelle L.VP, Quality
|
SaleCommon Stock | 1,168 | $20.27 | $23,676.64 |
DisclosureSEC source: 0000784199-24-000152 · wk-form4a_1710462815.xml · nonDerivative · entry 2 Maney Rochelle L. · CIK 0001850597 · VP, Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,214 F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 1,185 shares were sold, when in fact, 1,168 shares were sold. F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| February 26, 2024 Filed Mar 15, 2024 00:31 UTC Amendment |
Holloway Jean FSVP, General Counsel
|
SaleCommon Stock | 1,543 | $20.27 | $31,278.31 |
DisclosureSEC source: 0000784199-24-000150 · wk-form4a_1710462676.xml · nonDerivative · entry 4 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,852 F5 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 1,566 shares were sold, when in fact, 1,543 shares were sold. F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| February 26, 2024 Filed Mar 15, 2024 00:31 UTC Amendment |
Holloway Jean FSVP, General Counsel
|
SaleCommon Stock | 1,295 | $20.27 | $26,251.07 |
DisclosureSEC source: 0000784199-24-000150 · wk-form4a_1710462676.xml · nonDerivative · entry 2 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,559 F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 1,314 shares were sold, when in fact, 1,295 shares were sold. F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| February 26, 2024 Filed Mar 15, 2024 00:29 UTC Amendment |
GREEN ANDREW MVP Regulatory
|
SaleCommon Stock | 1,199 | $20.27 | $24,305.05 |
DisclosureSEC source: 0000784199-24-000148 · wk-form4a_1710462542.xml · nonDerivative · entry 4 GREEN ANDREW M · CIK 0001191000 · VP Regulatory 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,580 F5 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 1,218 shares were sold, when in fact, 1,199 shares were sold. F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| February 26, 2024 Filed Mar 15, 2024 00:29 UTC Amendment |
GREEN ANDREW MVP Regulatory
|
SaleCommon Stock | 1,168 | $20.27 | $23,676.64 |
DisclosureSEC source: 0000784199-24-000148 · wk-form4a_1710462542.xml · nonDerivative · entry 2 GREEN ANDREW M · CIK 0001191000 · VP Regulatory 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,865 F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 1,185 shares were sold, when in fact, 1,168 shares were sold. F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| February 26, 2024 Filed Mar 15, 2024 00:27 UTC Amendment |
Davis John EChief Commercial Officer
|
SaleCommon Stock | 1,875 | $20.27 | $38,008.31 |
DisclosureSEC source: 0000784199-24-000146 · wk-form4a_1710462424.xml · nonDerivative · entry 4 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,572 F5 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 1,904 shares were sold, when in fact, 1,875 shares were sold. F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| February 26, 2024 Filed Mar 15, 2024 00:27 UTC Amendment |
Davis John EChief Commercial Officer
|
SaleCommon Stock | 1,586 | $20.27 | $32,149.96 |
DisclosureSEC source: 0000784199-24-000146 · wk-form4a_1710462424.xml · nonDerivative · entry 2 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,711 F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 1,610 shares were sold, when in fact, 1,586 shares were sold. F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| February 26, 2024 Filed Mar 15, 2024 00:14 UTC Amendment |
Mackin James PPresident & CEO
|
SaleCommon Stock | 12,968 | $20.27 | $262,875.62 |
DisclosureSEC source: 0000784199-24-000134 · wk-form4a_1710461680.xml · nonDerivative · entry 4 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 696,253 F5 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 13,168 shares were sold, when in fact, 12,968 shares were sold. F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| February 26, 2024 Filed Mar 15, 2024 00:14 UTC Amendment |
Mackin James PPresident & CEO
|
SaleCommon Stock | 17,868 | $20.27 | $362,204.01 |
DisclosureSEC source: 0000784199-24-000134 · wk-form4a_1710461680.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 650,573 F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 18,144 shares were sold, when in fact, 17,868 shares were sold. F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| February 26, 2024 Filed Mar 15, 2024 00:04 UTC Amendment |
Getz Matthew AVP, Human Resources
|
SaleCommon Stock | 1,112 | $20.27 | $22,541.46 |
DisclosureSEC source: 0000784199-24-000126 · wk-form4a_1710461069.xml · nonDerivative · entry 4 Getz Matthew A · CIK 0001784253 · VP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,440 F5 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 1,128 shares were sold, when in fact, 1,112 shares were sold. F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| February 26, 2024 Filed Mar 15, 2024 00:04 UTC Amendment |
Getz Matthew AVP, Human Resources
|
SaleCommon Stock | 1,168 | $20.27 | $23,676.64 |
DisclosureSEC source: 0000784199-24-000126 · wk-form4a_1710461069.xml · nonDerivative · entry 2 Getz Matthew A · CIK 0001784253 · VP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,140 F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 1,185 shares were sold, when in fact, 1,168 shares were sold. F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 23:14 UTC |
Berry Lance AExecutive VP, CFO
|
GrantCommon Stock | 37,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000055 · wk-form4_1708989230.xml · nonDerivative · entry 1 Berry Lance A · CIK 0001478716 · Executive VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,064 F1 · shares: Represents shares of restricted stock that vest 33 1/3% per year beginning on the first anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan. Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 23:10 UTC |
Davis John EChief Commercial Officer
|
GrantCommon Stock | 19,734 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000053 · wk-form4_1708989044.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,911 F1 · shares: Represents shares of restricted stock that vest 33 1/3% per year beginning on the first anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan. Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 23:08 UTC |
Getz Matthew AVP, Human Resources
|
GrantCommon Stock | 9,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000051 · wk-form4_1708988912.xml · nonDerivative · entry 1 Getz Matthew A · CIK 0001784253 · VP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,942 F1 · shares: Represents shares of restricted stock that vest 33 1/3% per year beginning on the first anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan. Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 23:05 UTC |
GREEN ANDREW MVP Regulatory
|
GrantCommon Stock | 11,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000049 · wk-form4_1708988699.xml · nonDerivative · entry 1 GREEN ANDREW M · CIK 0001191000 · VP Regulatory 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,667 F1 · shares: Represents shares of restricted stock that vest 33 1/3% per year beginning on the first anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan. Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 23:01 UTC |
Holloway Jean FSVP, General Counsel
|
GrantCommon Stock | 19,610 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000047 · wk-form4_1708988421.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,468 F1 · shares: Represents shares of restricted stock that vest 33 1/3% per year beginning on the first anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan. Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 22:58 UTC |
Horton AmyVP, Chief Accounting Officer
|
GrantCommon Stock | 7,893 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000045 · wk-form4_1708988273.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,238 F1 · shares: Represents shares of restricted stock that vest 33 1/3% per year beginning on the first anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan. Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 22:55 UTC |
Mackin James PPresident & CEO
|
GrantCommon Stock | 89,001 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000043 · wk-form4_1708988118.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 628,037 F1 · shares: Represents shares of restricted stock that vest 33 1/3% per year beginning on the first anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan. Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 22:53 UTC |
Maney Rochelle L.VP, Quality
|
GrantCommon Stock | 7,893 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000041 · wk-form4_1708987968.xml · nonDerivative · entry 1 Maney Rochelle L. · CIK 0001850597 · VP, Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,016 F1 · shares: Represents shares of restricted stock that vest 33 1/3% per year beginning on the first anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan. Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 22:50 UTC |
Stanton Marshall S.SVP, Clinical & MD Affair
|
GrantCommon Stock | 14,800 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000039 · wk-form4_1708987779.xml · nonDerivative · entry 1 Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,703 F1 · shares: Represents shares of restricted stock that vest 33 1/3% per year beginning on the first anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan. Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 22:47 UTC |
THOMSON ROBERT CVP Research & Development
|
GrantCommon Stock | 8,165 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000037 · wk-form4_1708987643.xml · nonDerivative · entry 1 THOMSON ROBERT C · CIK 0001980521 · VP Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,291 F1 · shares: Represents shares of restricted stock that vest 33 1/3% per year beginning on the first anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan. Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 22:45 UTC |
Tyrs FlorianVP, Global Operations
|
GrantCommon Stock | 6,537 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000035 · wk-form4_1708987478.xml · nonDerivative · entry 1 Tyrs Florian · CIK 0001983377 · VP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,790 F1 · shares: Represents shares of restricted stock that vest 33 1/3% per year beginning on the first anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 22:25 UTC |
Horton AmyVP, Chief Accounting Officer
|
GrantCommon Stock | 6,418 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000074 · wk-form4_1709159070.xml · nonDerivative · entry 3 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,836 F3 · shares: Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 22:25 UTC |
Horton AmyVP, Chief Accounting Officer
|
GrantCommon Stock | 3,366 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000074 · wk-form4_1709159070.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,604 F1 · shares: Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 22:22 UTC |
Mackin James PPresident & CEO
|
GrantCommon Stock | 58,648 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000072 · wk-form4_1709158886.xml · nonDerivative · entry 3 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 708,945 F3 · shares: Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 22:22 UTC |
Mackin James PPresident & CEO
|
GrantCommon Stock | 40,404 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000072 · wk-form4_1709158886.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 668,441 F1 · shares: Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 22:18 UTC |
Holloway Jean FSVP, General Counsel
|
GrantCommon Stock | 12,836 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000070 · wk-form4_1709158686.xml · nonDerivative · entry 3 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,376 F3 · shares: Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 22:18 UTC |
Holloway Jean FSVP, General Counsel
|
GrantCommon Stock | 5,386 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000070 · wk-form4_1709158686.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,854 F1 · shares: Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 22:16 UTC |
Maney Rochelle L.VP, Quality
|
GrantCommon Stock | 6,418 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000068 · wk-form4_1709158544.xml · nonDerivative · entry 3 Maney Rochelle L. · CIK 0001850597 · VP, Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,615 F3 · shares: Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 22:16 UTC |
Maney Rochelle L.VP, Quality
|
GrantCommon Stock | 3,366 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000068 · wk-form4_1709158544.xml · nonDerivative · entry 1 Maney Rochelle L. · CIK 0001850597 · VP, Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,382 F1 · shares: Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 22:12 UTC |
Davis John EChief Commercial Officer
|
GrantCommon Stock | 12,736 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000065 · wk-form4_1709158363.xml · nonDerivative · entry 3 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,423 F3 · shares: Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 22:12 UTC |
Davis John EChief Commercial Officer
|
GrantCommon Stock | 5,386 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000065 · wk-form4_1709158363.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,297 F1 · shares: Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 22:07 UTC |
Getz Matthew AVP, Human Resources
|
GrantCommon Stock | 7,412 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000063 · wk-form4_1709158049.xml · nonDerivative · entry 3 Getz Matthew A · CIK 0001784253 · VP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,535 F3 · shares: Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 22:07 UTC |
Getz Matthew AVP, Human Resources
|
GrantCommon Stock | 3,366 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000063 · wk-form4_1709158049.xml · nonDerivative · entry 1 Getz Matthew A · CIK 0001784253 · VP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,308 F1 · shares: Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 22:04 UTC |
GREEN ANDREW MVP Regulatory
|
GrantCommon Stock | 6,914 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000061 · wk-form4_1709157861.xml · nonDerivative · entry 3 GREEN ANDREW M · CIK 0001191000 · VP Regulatory 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,762 F3 · shares: Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 22:04 UTC |
GREEN ANDREW MVP Regulatory
|
GrantCommon Stock | 3,366 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000061 · wk-form4_1709157861.xml · nonDerivative · entry 1 GREEN ANDREW M · CIK 0001191000 · VP Regulatory 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,033 F1 · shares: Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 22:01 UTC |
Stanton Marshall S.SVP, Clinical & MD Affair
|
GrantCommon Stock | 10,644 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000059 · wk-form4_1709157669.xml · nonDerivative · entry 3 Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,133 F3 · shares: Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 22:01 UTC |
Stanton Marshall S.SVP, Clinical & MD Affair
|
GrantCommon Stock | 5,386 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000059 · wk-form4_1709157669.xml · nonDerivative · entry 1 Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,089 F1 · shares: Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024. Read SEC document |
| February 23, 2024 Filed Mar 15, 2024 00:38 UTC Amendment |
Horton AmyVP, Chief Accounting Officer
|
GrantCommon Stock | 6,418 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000156 · wk-form4a_1710463100.xml · nonDerivative · entry 3 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,854 F4 · shares: Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date. F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| February 23, 2024 Filed Mar 15, 2024 00:38 UTC Amendment |
Horton AmyVP, Chief Accounting Officer
|
GrantCommon Stock | 3,366 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000156 · wk-form4a_1710463100.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,604 F1 · shares: Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.